Zevia PBC

Zevia PBC (ZVIA) Stock Analysis

$1.360

+0.181 (+13.33%)At close

Loading chart…
High
1.440
Open
1.390
VWAP
1.35
Volume
1.36M
Mkt Cap
47.25M
Low
1.250
Amount
1.83M
EV/EBITDA, TTM
-8.89

Zevia PBC is a beverage company. It develops, markets, sells, and distributes naturally delicious, zero-sugar beverages. The Company’s beverages are plant-based ingredients, contain no artificial sweeteners, and are non-GMO project verified, gluten-free, Kosher, and vegan. It markets its products under the Zevia brand across multiple beverage categories, including Soda, Energy Drinks and Organic Teas. Its flagship product, Soda, is available in 18 flavors across multiple packs, variety packs, and in limited time-offer flavors. It offers Energy drinks in eight flavors. Organic Tea is a zero-calorie, naturally sweetened ready-to-drink tea segment. It offers Organic Tea in eight flavors, including one caffeine-free option. Zevia products are distributed in more than 37,000 retail locations in the United States and Canada through a diverse network of retailers in the grocery, drug, warehouse club, mass, natural, convenience and ecommerce channels.

www.zevia.com

AI analysis of Zevia PBC (ZVIA)

Hold

Zevia PBC (ZVIA) is currently not a good buy. The stock is trading at $1.12, significantly down 44.28% year-to-date, and the RSI is at a very low 20.819, indicating oversold conditions. However, the recent downgrade by analysts and the company's ongoing losses raise concerns about its short-term viability. The main risk is the negative earnings per share (EPS) forecast of -0.0500 for the upcoming earnings report on November 4, 2026, which could further pressure the stock price.

Valuation Metrics

The current forward P/E ratio for Zevia PBC (ZVIA) is 0.00, compared to its 5-year average forward P/E of -10.32.

Forward P/E

Overvalued
5Y Average P/E
-10.32
Current P/E
0.00
Overvalued
-3.17
Undervalued
-17.47

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
15.27
Current EV/EBITDA
-8.89
Overvalued
100.34
Undervalued
-69.80

Forward P/S

Fair
5Y Average P/S
0.83
Current P/S
0.47
Overvalued
1.22
Undervalued
0.45

Alphio AI Price Scenarios for ZVIA

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ZVIA

$2.77

Scenario price

B

Base

Base · 50%ZVIA

$2.40

Scenario price

B

Bear

Bear · 25%ZVIA

$1.74

Scenario price

Whales holding ZVIA

C

Castle Hook Partners LP

+ HoldingZVIA

+8.76%

3M Return

Events Timeline

2026-11-04 (ET)

17:00:00

Sees Q4 Adjusted EBITDA Loss of $0.5M to $0.9M

17:00:00

Company Expects 2026 Net Sales of $177M to $179M

17:00:00

Zevia Reports Q3 Revenue of $48.3M, Exceeding Estimates

2026-10-22 (ET)

17:30:00

Zevia Enters $20M Convertible Preferred Stock Agreement with GP Investments

2026-08-05 (ET)

16:30:00

Company Expects Q3 2026 Adjusted EBITDA Loss of $3M-$3.5M

News

ZVIA FAQ — answered by Alphio AI

Zevia PBC is a beverage company. It develops, markets, sells, and distributes naturally delicious, zero-sugar beverages. The Company’s beverages are plant-based ingredients, contain no artificial sweeteners, and are non-GMO project verified, gluten-free, Kosher, and vegan. It markets its products under the Zevia brand across multiple beverage categories, including Soda, Energy Drinks and Organic Teas. Its flagship product, Soda, is available in 18 flavors across multiple packs, variety packs, and in limited time-offer flavors. It offers Energy drinks in eight flavors. Organic Tea is a zero-calorie, naturally sweetened ready-to-drink tea segment. It offers Organic Tea in eight flavors, including one caffeine-free option. Zevia products are distributed in more than 37,000 retail locations in the United States and Canada through a diverse network of retailers in the grocery, drug, warehouse club, mass, natural, convenience and ecommerce channels. It operates in the Consumer Non-Cyclicals sector (BOTTLED & CANNED SOFT DRINKS & CARBONATED WATERS industry).

Zevia PBC (ZVIA) is currently not a good buy. The stock is trading at $1.12, significantly down 44.28% year-to-date, and the RSI is at a very low 20.819, indicating oversold conditions. However, the recent downgrade by analysts and the company's ongoing losses raise concerns about its short-term viability. The main risk is the negative earnings per share (EPS) forecast of -0.0500 for the upcoming earnings report on November 4, 2026, which could further pressure the stock price.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading